Hot Investor Mandate 2: Corporate Venture Arm of Large Medtech Company Seek to Invest and Partner with Medical Device Companies in Cardiovascular, Diabetes, Among Other Indications

8 Mar

A corporate investment group invests strategically on behalf of a large medical technology corporate. The firm uses a variety of structures to work with early stage medical technology companies, including both licensing relationships and equity investments on a case by case basis. The firm is a flexible investor, and the firm’s allocation sizes are wide ranging. The firm invests worldwide.

The firm invests in sectors that are relevant to the corporate’s business groups – areas of interests include cardiovascular, diabetes, restorative therapies, and minimally invasive therapies. This includes interests in spinal implants, neuromodulation treatments for pain and urological disorders, deep brain stimulation, neurovascular devices, general surgery, gastrointestinal care, pulmonology, respiratory care and monitoring technologies, etc. The firm is interested in diversifying the corporate’s product and services offerings within all of these areas of interests and also in integrating new fields of information technology and services into the strategic areas, such as IT-enabled patient monitoring and contract management of provider facilities. The firm invests at a range of development stages but generally prefers to work with companies that have obtained clinical data regarding their asset.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: